Authors: Volumenie, JL Polak, M Guibourdenche, J Oury, JF Vuillard, E Sibony, O Reyal, F Raccah-Tebeka, B Boissinot, C Madec, AM Orgiazzi, J Toubert, ME Leger, J Blot, P Luton, D

Citation: Jl. Volumenie et al., Management of fetal thyroid goitres: a report of 11 cases in a single perinatal unit, PRENAT DIAG, 20(10), 2000, pp. 799-806

Authors: Tree, TIM Morgenthaler, NG Duhindan, N Hicks, KE Madec, AM Scherbaum, WA Banga, JP

Citation: Tim. Tree et al., Two amino acids in glutamic acid decarboxylase act in concert for maintainance of conformational determinants recognised by Type I diabetic autoantibodies, DIABETOLOG, 43(7), 2000, pp. 881-889

Authors: Schwartz, HL Chandonia, JM Kash, SF Kanaani, J Tunnell, E Domingo, A Cohen, FE Banga, JP Madec, AM Richter, W Baekkeskov, S

Citation: Hl. Schwartz et al., High-resolution autoreactive epitope mapping and structural modeling of the 65 kDa form of human glutamic acid decarboxylase, J MOL BIOL, 287(5), 1999, pp. 983-999

Authors: Mayer, A Rharbaoui, F Thivolet, C Orgiazzi, J Madec, AM

Citation: A. Mayer et al., The relationship between peripheral T cell reactivity to insulin, clinicalremissions and cytokine production in type 1 (insulin-dependent) diabetes mellitus, J CLIN END, 84(7), 1999, pp. 2419-2424

Authors: Rharbaoui, F Mayer, A Granier, C Bouanani, M Thivolet, C Pau, B Orgiazzi, J Madec, AM

Citation: F. Rharbaoui et al., T cell response pattern to glutamic acid decarboxylase 65 (GAD65) peptidesof newly diagnosed type 1 diabetic patients sharing susceptible HLA haplotypes, CLIN EXP IM, 117(1), 1999, pp. 30-37